HOME > TOP STORIES
TOP STORIES
-
BUSINESS Japan Pharma Market Forecast to Decline through FY2025: IQVIA
June 25, 2021
-
ACADEMIA Reproductive Medicine Society Issues Fertility Treatment Guidelines, Prods Careful Design for Health Coverage
June 25, 2021
-
REGULATORY Japan Approves Verquvo, Evrysdi, 2 CGRP Migraine Meds and More
June 24, 2021
-
REGULATORY Japan to Stop Accepting Requests for Moderna Vaccines for Workplace Inoculations
June 24, 2021
-
BUSINESS MSD Tops Foreign Pharma List in Japan in FY2020, but Big Players in a Melee
June 23, 2021
-
BUSINESS Otsuka Group Takes the Lead to Launch Workplace Vaccination as Industry Peers Set to Follow
June 22, 2021
-
BUSINESS Global Brands Clinch Targeted Sales despite COVID-19, Drive Japan Makers in FY2020
June 21, 2021
-
REGULATORY Japan OKs 2021 Fiscal Policy Blueprint, Vows Transparency in Drug Pricing
June 21, 2021
-
REGULATORY MHLW Aims to Set Up Evaluation Index, Sakigake System for SaMD by March
June 18, 2021
-
BUSINESS Merck’s COVID-19 Drug Candidate Enters PIII in Japan
June 18, 2021
-
BUSINESS Kyowa Adjusting Cymbalta Generic Supply before Launch as Rivals Delay Release
June 18, 2021
-
BUSINESS Delays in Cymbalta Generic Launch Stir Worries on Demand Spike for 2 Makers
June 17, 2021
-
REGULATORY Report Systems for Improper Drug Promotion Little-Known among Pharmacists: MHLW Study
June 16, 2021
-
REGULATORY Honebuto Text to Add Line for “Transparency and Predictability” of Drug Pricing System
June 16, 2021
-
BUSINESS Daiichi Sankyo Drops Nafamostat Development for COVID-19
June 16, 2021
-
BUSINESS Shipment Curbs of 3,000-Plus Products Taking a Toll on Wholesalers as Generic Woes Continue
June 15, 2021
-
ORGANIZATION Saitama-Based Hospital Group Introduces Formulary in 18 Therapeutic Areas, Aims to Spread Know-How in Region
June 15, 2021
-
ORGANIZATION FPMAJ Drug Price Report Rebuts Issues Raised over Cost-Plus Method, PMP and More
June 14, 2021
-
BUSINESS Japan Approves 1st Oncolytic Virus, Delytact, for Malignant Glioma
June 14, 2021
-
REGULATORY LDP Flags 80% Generic Target for All Prefectures: Honebuto Debate
June 11, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
